Bala'i na Antiphospholipid Syndrome (CAPS / Asherson's Syndrome): Multi-Gabobin Microvascular Thrombosis Storm A cikin Mako Daya da Farfaji Sau uku tare da Plasmapheresis¶

** Cutar Cutar Antiphospholipid (Cetastrophic)CAPS, wanda kuma aka fi sani da suna Asherson's Syndrome bayan Dr. Ronald Asherson, wanda ya fara bayyana shi a cikin 1992)** shine bambance-bambancen da ke barazanar rayuwa na Antiphospholipid Syndrome (APS, mai yawo kasa da kasa 1 percent marasa lafiya na APS (with nearly 50 percent of cases occurring as the very first clinical presentation in a patient who never knew they had APS). Ganin cewa APS na gargajiya yakan haifar da babban jijiya ko guda ɗaya.such as a single deep vein thrombosis, pulmonary embolism, or stroke) ko hasarar ciki akai-akai, CAPS wani abu ne mai fashewa, mai haɓakawa "guguwar thrombotic" (Thrombotic Microangiopathy [TMA] + Ciwon kumburin ƙwayar cutaSIRS]) wannan lokaci guda yana ɓoye ƙananan ƙananan ƙwayoyin cuta na ** uku ko fiye da tsarin gabobin cikin ƙasa da kwanaki 7, mafi yawan lokuta ** kn.73%: m hauhawar jini, proteinuria, da m renal gazawar)**, ** huhu (60%: ARDS, embosm na huhu, da zubar jini na alveolar) ***, ** kwakwalwa (56%: shanyewar ji, ciwon zuciya, bugun jini na kwakwalwa, da ciwon kwakwalwa)**, ** zuciya (50%: mic-infarction myocardial da Libman-Sacksawul ciyayi)**, ** fata (47%: lido racemosaraɗaɗi na dijital ischemia, da cutaneous necrosis), da ** adrenal gland (bilateral adrenal hemorrhage/infarction causing refractory hypotensive shock). Saboda CAPS ana taar da shi ta hanyar "Buga Biyu", inda preexising hh-titer ** antiphospholipid antibodies (Lupus Anticoagulant [LA], klzzh:0015, kuma Anti-Beta-2-Glycoprotein-I [aB2GPI] IgG/IgM** Ana kunna wuta ta hanyar "Buga na Biyu" mai faɗakarwa (bacterial or viral infection in 49%, surgical procedures or trauma in 17%, abrupt withdrawal or subtherapeutic INR of Warfarin, malignancy, pregnancy/puerperium, or oral contraceptive estrogen), jinkirin jinkiri yana ɗaukar **80 to 90 percent Yawan mace-mace *, yayin da farawar ICU nan da nan na ** CAPS "Triple Therapy" yana yanke mace-mace cikin rabi. Idan mai haƙuri tare da sanannun Lupus (SLE), Ciwon Antiphospholipid, ko thrombocytopenia wanda ba a bayyana shi ba yana tasowa alamun ƙwayoyin cuta masu yawa kwatsam (shortness of breath, confusion, chest or flank pain, mottled purple skin, or dark/absent urine), kira na gida lambobin gaggawa nan da nan. Hakanan duba jagororin abokanmu akan rikicin adrenal da cutar Addison ta gaggawa allurar, eclampsia seizures, ciwon HELLP, da preeclampsia bayan haihuwa, kuma sepsis da septic shock.

Sashen gaggawa na gaggawa da fifikon ICU shine ** ƙaddamar da cikakken "CAPS Triple Therapy" a lokaci guda a farkon zargin asibiti na ƙwayoyin cuta na ƙwayoyin cuta masu yawa.WITHOUT waiting days for confirmatory antiphospholipid antibody titers or tissue biopsy: ** (1) Magungunan Heparin marasa ƙarfiUFH (not only to halt fibrin clot propagation, but because heparin directly inhibits complement activation [C3/C5 convertase]), ** (2) Babban Maganin Corticosteroids na Jiki (Methylprednisolone 500 to 1,000 mg/day IV for 3 days, followed by 1 to 2 mg/kg/day*** (to extinguish the NF-kappa-B endothelial cytokine storm), da (3) Musanya Kwayoyin Jiyya na yau da kullum (Plasmapheresis / TPE musanya 1.0 zuwa 1.5 juzu'in plasma akan Fresh Frozen Plasma/Albumin) DA/KO Babban Kashi na ImmunoglobulinIVIG, 0.4 g/kg/day IV for 5 days, yayin da ake kula da abin da ke haifar da kamuwa da cuta tare da maganin rigakafi masu yawa da kuma tura ** anti-C5 m complement inhibitor. Eculizumab (Soliris) ko anti-CD20 Rituximab* don abubuwan da ba su dace ba.

Yi wannan yanzu¶

1. Kira lambar gaggawa ta gida ko kunna ICU / Hematology / Rheumatology Amsa Saurin gaggawa idan majiyyaci ya kamu da thrombosis na lokaci guda ko rashin aikin gabobin jiki >= 2 to 3 gabobi a cikin mako guda. Dial 911 a Amurka da Kanada, 999 a Burtaniya, 112 a fadin Tarayyar Turai, 000 a Ostiraliya, ko tuntuɓi littafinmu na lambobin gaggawa. Ka tuna cewa 46 to 50 percent na marasa lafiya na CAPS ba su da wani ganewar asali na APS ko Lupus (SLE* kafin a shiga dakin gaggawa.
2. Fara ginshiƙi na 1 na CAPS Sau uku Therapy Nan da nan: Therapeutic Intravenous Unfractionated Heparin (UFH) (Even in the Presence of Moderate Thrombocytopenia or Diffuse Alveolar Hemorrhage).
3. Heparin wanda ba shi da fa'ida shine ginshiƙin tilas na rayuwa ta CAPS (reducing mortality from > 75% to about 30% a cikin International CAPS Registry) duka ta hanyar maganin rigakafi na maganin thrombin da kai tsaye ** hanawa na gargajiya da madadin hanyoyin haɗin gwiwa ***.
4. ** Lu'u-lu'u mai mahimmanci na Kulawa na Laboratory (The Lupus Anticoagulant aPTT Trap):** Domin majiyyaci yana zagayawa ** Lupus Anticoagulant (LA*** ƙwayoyin rigakafi na wucin gadi suna tsawaita tushen tushen phospholipid.aPTT** (often to 60 to 100+ seconds * kafin * heparin har ma an fara), saka idanu na heparin na IV marasa ƙarfi tare da ma'auni aPTT zai yaudare ku cikin ** tsananin rashin amfani da heparin**. ** Koyaushe saka idanu na Heparin marasa ƙarfi na IV a cikin CAPS ta amfani da chromogenic Anti-Factor Xa (Anti-Xa) bincike (target 0.3 to 0.7 IU/mL), BA TABBAS misali aPTT.**
5. Fara Pillar 2 na CAPS Sau Uku Farfasa Nan da nan: Pulse Intravenous Methylprednisolone (500 to 1,000 mg IV Once Daily for 3 Consecutive Days, Mai biyo baya 1 to 2 mg/kg/day IV) Kada a taba ba da corticosteroids * kadai * ba tare da maganin hana jini a cikin CAPS ba, amma tare da IV Heparin da Plasmapheresis, babban adadin IV Methylprednisolone yana rufe ** Anti-Beta-2-Glycoprotein-I (aB2GPI*** kunna endothelial NF-kappa-B kuma Tissue Factor bayyanar cututtuka kuma a lokaci guda yana rufe ** matsanancin zubar jini na adrenal na biyu / ciwon ciki ** (which complicates 13% to 26% of CAPS cases).
6. Fara ginshiƙi na 3 na CAPS Sau Uku Therapy A cikin Sa'o'i: Musanya Plasma na yau da kullun (Plasmapheresis / TPE) DA/KO Babban Kashi na Jiki Immunoglobulin (IVIG).
7. ** Musanya Plasma Therapeutic (TPE, Layin Farko musamman lokacin da Schistocytes / Microangiopathic Hemolytic Anemia [MAHA] ko gazawar Renal akwai):** Musanya 1.0 to 1.5 plasma volumes kullum na akalla kwanaki 3 zuwa 5 ta amfani da Frozen PlasmaFFP) (ko 50:50 FFP + 5% Albumin) don cire ƙwayoyin cuta ta hanyar inji aB2GPI kuma aCL autoantibodies, cytokines (IL-1, IL-6, TNF-alpha), da kuma cika gutsuttsura yayin da ake sake cika magungunan kashe kwayoyin halitta (anticoagulants).Antithrombin, Protein C, Protein S, and ADAMTS13).
8. ** Babban Kashi IVIG (0.4 g/kg/day IV for 5 days ko 1.0 g/kg/day for 2 days):** Gudanar da ko dai shi kaɗai (idan apheresis catheter placement ko TPE aka jinkirta) ko ** nan da nan bayan kowane zaman Plasma Musanya yau da kullun** (never infuse IVIG right *before* a TPE session, or the apheresis machine will wash your expensive IVIG straight into the waste bag).
9. ** Farautar Kashe Kashe kuma Ka Yi Magance Maƙarƙashiya "Buge Na Biyu" (Na Biyu)Infection in 49% of Cases.** Zana STAT na gefe da al'adun jini na layi, al'adun fitsari, da faifan hoto, sannan a fara ** maganin rigakafi mai fa'ida mai fa'ida da yawa** nan da nan idan ana zargin wani zazzabi ko tushen kamuwa da cuta. Kar a taɓa dakatar da maganin ƙwanƙwasawa kwatsam kafin a yi masa tiyata a cikin sanannen majinyacin APS mai Sau uku (Uku).always bridge closely with IV UFH or therapeutic LMWH).
10. ** Sanya Hana Haɗin Ƙarshen Tasha (IV Eculizumab 900 mg Mako-mako) ko Rituximab Farkon Refractory CAPS ko Fitaccen TMA (Schistocytes + Severe Thrombocytopenia + Renal Failure.** Shaidar gwaji da na asibiti sun tabbatar da cewa mai tsananin CAPS yana kora ta hanyar gudu Terminal Complement Complex (C5b-9 membrane harin hadaddun) sanyawa akan sel endothelial (often with underlying complement regulatory gene mutations). Bayarwa ** IV Eculizumab (Soliris*** yana dakatar da hemolysis na intravascular, thrombocytopenia, da thrombosis na microvascular na renal a cikin sa'o'i 48 zuwa 72 lokacin da daidaitaccen farfaɗo na Triple bai isa ba.

Bishiyar yanke shawara: da ake zargin Bala'i na Antiphospholipid Syndrome (CAPS / Asherson's Syndrome) da ICU Sau uku Therapy¶

flowchart TD
    Patient["Marasa lafiya yana Gabatar da Ci gaba da Saurin Cigaban Gaɓoɓin Gabas (> = Gabobin 3 A cikin < Kwanaki 7): <br/> - Renal: Raunin Koda, Malignant HTN, Proteinuria <br/> - Pulmonary: ARDS / Diffuse Alveolar Hemorrhage / PENS: Encephalopathy CVST <br/>- Cardiac: Babban Troponin, Myocardial Microthrombi <br/> - Skin: Livedo Racemosa, Digital Gangrene, Skin Necrosis <br/> - Adrenal: Flank / Ciwon Ciki + Refractory Hypotension"] --> StatWorkup["STAT Bedside & Lab Triage (Kada Ku Jinkirta Jiyya don Sakamakon Yaƙin Jiki):<br/>1. Smear Peripheral (Schistocytes), LDH, Haptoglobin, Platelets, Coags, Fibrinogen <br/>2. Zana Lupus Anticoagulant (dRVVT/aPTT), Anti-Cardiolipin IgG/IgM, & Anti-Beta-2-Glycoprotein-I IgG/IgM (KAFIN Musanya Plasma) <br/>3. Zana Bazuwar Cortisol & ACTH (Bincika jinin Jikin Adrenal na Biyu) + Ayyukan ADAMTS13 (Rule Out TTP)"]

    StatWorkup --> TripleTherapy["Ƙaddamar da EMPIRIC 'CAPS THERAPY' NAN NAN A CIKIN ICU"]

    TripleTherapy --> Pillar1["PILLAR 1: Therapeutic IV Unfractionated Heparin (UFH) <br/> - Saka idanu sosai tare da Chromogenic ANTI-FACTOR Xa Level (Manufa 0.3 zuwa 0.7 IU / mL)"]

    TripleTherapy --> Pillar2["PILLAR 2: High-Dose IV Corticosteroids <br/> - IV Methylprednisolone 500 zuwa 1,000 MG kowace rana don 3 Days, Sa'an nan 1 zuwa 2 mg / kg / rana <br/> - Yana toshe NF-kappa-B Endothelial Storm & Magance Rikicin Adrenal"]

    TripleTherapy --> Pillar3["PILLAR 3: Musanya Plasma na yau da kullun (TPE) +/- Babban Kashi IVIG <br/>- Musanya 1.0 zuwa 1.5 Plasma Volume Daily x 5+ Days Amfani da Fresh Frozen Plasma (FFP)"]

    Pillar1 --> TriggerAndRefractory{"Magance 'Tsarin Buga Na Biyu' (Antibiotics Broad-Spectrum Antibiotics Idan Kowanne Kamuwa Ne) & Tantance Amsar Sa'o'i 24 zuwa 48"}
    Pillar2 --> TriggerAndRefractory
    Pillar3 --> TriggerAndRefractory

    TriggerAndRefractory -->|"Thrombocytopenia Refractory, MAHA Schistocytes na ci gaba, ko Ragewar Gaba"| AddEculizumab["ESCALATE IMMEDIATELY:<br/>1. IV Eculizumab (Anti-C5 Complement Inhibitor: 900 mg IV Weekly x 4, Then 1,200 mg) [Give Meningococcal Vaccine + Ciprofloxacin/Penicillin Prophylaxis]<br/>2. IV Rituximab (375 mg/m2 Weekly x 4) to Deplete B-Cell Autoantibody Production"]

Sashe na 1: "Buga Biyu" Pathophysiology na Ciwon Asherson da Ma'auni na Ganewar Duniya¶

1. Me Yasa Surukan Antiphospholipid Antibodies Kwatsam Ya Fashe A Cikin Guguwar Gabas Da yawa Na Kwanaki 7¶

Yawancin mutane suna tafiya tsawon shekaru tare da kewayawa ** "Triple-Positive" antiphospholipid antibodies (Lupus Anticoagulant + Anti-Cardiolipin + Anti-Beta-2-Glycoprotein-I*** ba tare da tasowa jini ba ("The First Hit"). Me yasa? Domin a ƙarƙashin yanayin hutu na yau da kullun, ƙwayoyin jijiyoyi na jijiyoyi suna ɓoye mummunan cajin membrane phospholipids akan takarda na ciki, kuma suna yawo ** Beta-2-Glycoprotein-I (B2GPI*** yana yawo a cikin rufaffiyar madauwari mai ma'ana wanda ke ɓoye yankin daurewar antigenic (Domain I).

• Haɗar "Buga Na Biyu"Infection, Surgery, Trauma, Pregnancy, or Warfarin Withdrawal::
• Lokacin kamuwa da cuta (infection).Gram-negative sepsis, respiratory virus, urinary tract infection), raunin nama na tiyata, ko rikicewar mahaifa yana lalata ko kunna ƙwayoyin jijiyoyi na jijiyoyi, phosphatidylserine da aka caji mara kyau yana jujjuya saman tantanin halitta na waje.
• Yawo B2GPI yana ɗaure da endothelium da ya lalace kuma ya buɗe cikin buɗaɗɗen nau'in kifin kifi mai siffar J**, yana fallasa ** Domain I ***.
• Mai cutarwa klzzwxh:02 da Annexin A2**, nna NF-kappa-Bkumap38 MAPK.
• ** Madaidaicin Ƙaddamarwa (C3a / C5a / C5b-9):** Daure aB2GPI hadaddun garkuwar jiki suna haifar da gagarumin kunnawa na Classical and Madadin Kammala Hanyoyi, suna haifar da anaphylatoxins C3a kuma C5a (which recruit neutrophils to extrude prothrombotic NETs) da naushi **C5b-9 Membrane Attack Complex pores *** zuwa cikin ƙwayoyin jijiyoyi na endothelial microvascular a ko'ina cikin kodan, huhu, kwakwalwa, zuciya, da glandar adrenal.

2. Ma'auni na Farko na Farko na hukuma don APS mai bala'i (Asherson et al. International Consensus)¶

Likitoci suna rarraba majiyyaci a matsayin yana da Tabbataccen CAPS (all 4 criteria) ko Mai yiwuwa CAPS (3 of 4 criteria) bisa: 1. Shari'a na 1>= 3 Organs, Systems, or Tissues): Shaida ta asibiti na shigar da gaɓoɓi uku ko fiye, tsarin, da/ko kyallen takarda** (renal, pulmonary, cerebral, cardiac, cutaneous, hepatic, gastrointestinal/mesenteric, splenic, or adrenal). 2. Shari'a 2<= 7 Days): Ci gaban bayyanar cututtuka na asibiti ** lokaci guda ko cikin ƙasa da mako guda**. 3. Shari'a 3Histopathologic Microthrombosis): Tabbatarwa ta hanyar histopathology na ** ƙanƙantar ƙaramin jirgin ruwa (thrombotic microangiopathy) aƙalla gaba ɗaya ko nama** (typically via skin punch biopsy of livedo/necrotic lesions or renal biopsy once stabilized). 4. Shari'a na 4Laboratory Antiphospholipid Antibodies): Kasancewar ** Lupus Anticoagulant (LA*** Anti-Cardiolipin (Anti-Cardiolipin)aCL IgG/IgM a matsakaici-zuwa-high titer > 40 GPL/MPL ko > 99th percentile***, da/ko Anti-Beta-2-Glycoprotein-IaB2GPI IgG/IgM).

• Lokacin da za a gano "Mai yiwuwa CAPS" da kuma Bi da Kai Nan da nan a Bedside: Saboda yin biopsy na koda a cikin rashin lafiya mai tsanani, anticoagulated, thrombocytopenic ICU mai haƙuri yana da haɗari kuma yana jiran makonni 12 don sake tabbatar da maganin rigakafi ba zai yiwu ba a lokacin rikici mai tsanani, Yarjejeniyar Kasa da Kasa ta bayyana ** Ƙimar CAPS ** a duk lokacin da:
• Gabobin jiki guda 2 ne kawai suka shiga ciki (with Criteria 2, 3, and 4 met), KO
• Dukkan sharuɗɗa 4 sun cika ban da ** tabbacin biopsy histopathologic ya ɓace** (because the patient is too unstable/anticoagulated to biopsy), KO
• 3 organs ci gaba da thrombosis sama da makonni 1 zuwa 4** duk da maganin hana jini.
• Dokar asibiti: Mayar da Mai yiwuwa CAPS daidai da Tabbataccen CAPS tare da cikakken ** Farfasa Sau uku**.

Sashe na 2: Daban-daban na gefe-da-gefe na ICU Thrombotic MicroangiopathiesCAPS vs. TTP vs. HUS/aHUS vs. HIT vs. Sepsis DIC)¶

Lokacin da mai haƙuri na ICU ya haɓaka da sauri platelets, haɓakar creatinine, rikicewar jijiyoyin jiki, da anemia na hemolytic tare da schistocytes.helmet cells* akan smear na jini, bambanta ** CAPS ** daga ** Thrombotic Thrombocytopenic Purpura (TTP**, Madaidaicin-Matsakaici-Cikin Ciwon Uremic Hemolytic (aHUS*, ** BUGA ***, da ** Septic DIC *** yana da mahimmanci:

Sashe na 3: Zurfafa-Tsaye Cikin Gaggawar Gaggawar Gaggawa 6 na CAPS (Cikin Ciwon Jini na Adrenal na Biyu da Jini na Alveolar)¶

Lokacin gudanar da majinyacin CAPS a cikin ICU, likitocin dole ne su bincika da sarrafa rikice-rikicen gabobin sa hannu guda shida waɗanda ke ƙayyade rayuwa:

========================================================================
   THE 6 SIGNATURE MULTI-ORGAN THROMBOTIC CRISES OF CAPS (ASHERSON'S)
========================================================================

  1. RENAL TMA (73%):               2. PULMONARY CRISIS (60%):
     Renal interlobular/glomerular     ARDS, Pulmonary Embolism, AND
     capillary microthrombi ->         Capillaritis DIFFUSE ALVEOLAR
     Malignant HTN + Oliguric AKI.     HEMORRHAGE (DAH: Hemoptysis +
                                       Falling Hb + Ground-Glass CT).
  3. CEREBRAL / CNS (56%):             * CRITICAL PEARL: Even with DAH,
     Microvascular Encephalopathy,       continue carefully titrated IV
     Seizures, Ischemic Stroke, &        Heparin + Pulse Steroids + TPE.
     Cerebral Venous Sinus Clots.
                                    4. CARDIAC MICRO-INFARCTION (50%):
  5. CUTANEOUS ISCHEMIA (47%):         Intramyocardial microthrombi
     Branching Livedo Racemosa,        (cardiogenic shock with clean
     Splinter Hemorrhages, Digital     epicardial coronaries) + Sterile
     Cyanosis/Gangrene, Skin Ulcers.   Libman-Sacks Mitral/Aortic Valves.

  6. BILATERAL ADRENAL HEMORRHAGE / INFARCTION (13% to 26% - OFTEN MISSED.):
     * Why the Adrenal Glands? Each adrenal gland is fed by 3 arteries
       (50-60 arterioles) but drained by ONLY A SINGLE CENTRAL ADRENAL VEIN.
     * Thrombosis of that single central adrenal vein causes hemorrhagic
       venous infarction of both adrenal cortices -> Sudden Flank/Abdominal
       Pain, Hyponatremia, Hyperkalemia, & Catecholamine-Resistant Shock.
     * Lifesaving Fix: Immediate Stress-Dose IV Hydrocortisone (100 mg IV
       bolus, then 50 mg IV q6h) or Pulse IV Methylprednisolone.
========================================================================

.Why CAPS Causes Acute Addisonian Adrenal Crisis)¶

Me yasa ** zubar da jini na adrenal na biyu / ciwon ciki *** babban rikitarwa na duka ** CAPS *** da ** BUGA ? - Kowane mutum adrenal gland yana da wadataccen wadatar jijiya (superior, middle, and inferior suprarenal arteries branching into 50+ capillary plexus vessels), amma duk jini mai jijiya dole ne ya fita ta hanyar guda daya, kadaici ta tsakiya adrenal vein (creating a vascular "water-hammer" bottleneck rich in platelet-activating catecholamines). - Lokacin da CAPS microthrombi ya ɓoye waccan jijiya ta tsakiya guda ɗaya a gefe biyu, matsa lamba na venous a cikin cortex na adrenal ya hau sama har sai gland ya rushe da zubar jini a ciki ( Waterhouse-Friderichsen-kamar ciwon jini na jini*). - ** Red Flags na asibiti: *** Idan mara lafiya tare da APS/CAPS ya haɓaka ** sabon gefen gefe, baya, ko ciwon epigastric, zazzabi mara bayyana, faɗuwar ƙwayar sodium.hyponatremiaPotassium yana ƙaruwa (hyperkalemia), da hypotension refractory zuwa norepinephrine **, oda nan da nan ** Ciki CT ** (which shows enlarged, hyperdense edematous adrenal glands), zana ** STAT bazuwar maganin Cortisol da ACTH , kuma ** nan take gudanarwa 100 mg IV Hydrocortisone bolus ya biyo baya 50 mg IV kowane awa 6(or make sure the patient is already receiving Pulse IV Methylprednisolone).

2. The Pulmonary Paradox: Sarrafa Difffuse Alveolar Hemorrhage (DAH) Ciki da Guguwar Prothrombotic¶

Har zuwa 60 percent na marasa lafiya na CAPS suna haɓaka rashin ƙarfi na numfashi daga ARDS, ** thromboembolism na huhu , ko ** marasa thrombotic pulmonary capillaritis wanda ke haifar da Diffuse Alveolar Hemorrhage.DAH: hemoptysis, yada alveolar bilateral infiltrates a kan kirji CT, da kuma 1.5 to 3.0 g/dL overnight drop in hemoglobin). - How Can a Clotting Disease Cause Lung Bleeding? In CAPS, aB2GPI antibodies and C5a trigger immune-complex pulmonary capillaritis (neutrophilic inflammation that necroses the alveolar capillary wall) combined with pulmonary venular microthrombosis that raises hydrostatic capillary back-pressure until red blood cells pour into the air sacs. - How to Manage DAH in CAPS: 1. Immediately escalate immunosuppression with Pulse IV Methylprednisolone (1,000 mg/day IV x 3 days) + Daily Therapeutic Plasma Exchange (TPE) + IV Cyclophosphamide or Rituximab. 2. Carefully Balance Anticoagulation: If alveolar bleeding is life-threatening and platelets/fibrinogen are critically low, hold IV unfractionated heparin briefly for a few hours while administering Pulse Steroids and Plasma Exchange, but resume low-dose/titrated IV Unfractionated Heparin as soon as active hemoptysis stabilizes, because withholding heparin for days in CAPS allows microvascular thrombosis to destroy the brain, heart, and kidneys.

Part 4: Step-by-Step ICU Triple Therapy Execution & Refractory Rescue (Eculizumab & Rituximab)¶

1. The Exact CAPS Triple Therapy Checklist (McMaster / EULAR / International CAPS Registry Guidelines)¶

2. Ceto Halittun Halittu-Layi na Biyu don Ƙarfafa CAPS (Eculizumab kuma Rituximab)¶

Idan majinyacin CAPS ya ci gaba da fuskantar faɗuwar platelet, haɓakar creatinine, sabon ƙarancin jijiyoyi, ko hemolysis na microangiopathic mai jujjuyawa bayan awanni 24 zuwa 48 na Therapy Triple : 1. ** Toshewar Ƙarshen Ƙarshe (IV Eculizumab [Soliris] ko Ravulizumab [Ultomiris]:: - ** Me Yasa Yana Aiki: *** Over 60 percent na marasa lafiya da ke da tashar jiragen ruwa na CAPS mai karfin gaske.and many carry heterozygous mutations in complement regulatory genes like CFH, CFI, or CD46 identical to atypical HUS). Eculizumab (a humanized monoclonal antibody against complement protein C5) toshe tsagewar C5 cikin C5a kuma C5b-9, kama endothelial TMA lalacewa a cikin awanni 24 zuwa 72 . - Dogara:900 mg IV sau ɗaya kowane mako na makonni 4 , sai 1,200 mg IV a mako na 5 da kowane mako 2 bayan haka. - Wajibi na rigakafin Meningococcal: Domin toshewa C5b-9 yana haifar da mai saurin kamuwa da cuta Neisseria meningitidis, mai sarrafa ** qudrivalent (MenACWYda Serogroup B (MenBAlurar riga kafi na meningococcal nan da nan kuma a fara ** maganin rigakafi na baka na yau da kullun.Ciprofloxacin 500 mg daily ko Penicillin V 500 mg twice daily* daga ranar 1 ga Eculizumab (do not delay Eculizumab for 2 weeks waiting for vaccine immunity). 2. B-Cell DepletionIV Rituximab:: - Mai Gudanarwa Rituximab (375 mg/m2 IV sau ɗaya a mako har tsawon makonni 4, ko 1,000 mg IV on Days 1 and 15) (infused after daily TPE) to eliminate CD20+ B-lymphocytes samar da pathogenic antiphospholipid autoantibodies, musamman a CAPS marasa lafiya tare da tsanani thrombocytopenia, yada alveolar hemorrhage, ko cardiac/CNS sa hannu.

Lambobin gaggawa na yanki da rajistar CAPS na duniya¶

• Amurka da Kanada: Kiran kira 911 ga duk wani da ake zargi da cutar tabarbarewar gabobin jiki ko bugun jini/na gaggawar PE. Bi ** Jagoran Ayyukan Clinical na Jami'ar McMaster don Bincike da Gudanar da Ciwon Cutar Antiphospholipid (Catastrophic Antiphospholipid Syndrome)Blood Advances*** da ** Kwalejin Rheumatology ta Amurka (ACR) /ASH** shiriya.
• ** Tarayyar Turai da Burtaniya:** Kiran kira 112 a cikin EU ko 999 a Burtaniya. Bi ** Ƙungiyoyin Ƙungiyoyin Turai don Rheumatology (EULAR) Shawarwari don Gudanar da Ciwon Cutar Antiphospholipid a cikin Manya (Tektonidou et al., Annals of the Rheumatic Diseases*** da kuma British Society for HematologyBSH) Jagora. Likitoci a duk duniya na iya tuntuɓar su da shigar da kararraki tare da rajistar CAPS ta ƙasa da ƙasa (ontocrf.costaisa.com/en/web/caps, wanda taron Turai kan Antiphospholipid Antibodies ya shirya a Asibitin Clínic a Barcelona, ​​​​Spain, wanda Dr. Ricard Cervera ya jagoranta)**.
• ** Ostiraliya da New Zealand:** Kiran kira 000 a Ostiraliya ko 111 a New Zealand. Bi THANZ da ** Ƙungiyar Rheumatology ta Australiya (ARA** Ka'idojin ICU don Saurin warkewa da samun damar Eculizumab na gaggawa.

Tambayoyin da ake yawan yi¶

Yaya Catastrophic Antiphospholipid Syndrome (CAPS) ya bambanta da ciwon Antiphospholipid na yau da kullun (APS)?¶

In classic Antiphospholipid Syndrome (APS), patients typically experience a single isolated blood clot in a large vein or artery (such as a deep vein thrombosis in one leg, a pulmonary embolism, or a stroke) or recurrent pregnancy complications, with normal function in the rest of their organs. Catastrophic Antiphospholipid Syndrome (CAPS, or Asherson's Syndrome) affects less than 1 percent of APS patients and acts like a sudden, body-wide microvascular "thrombotic storm": instead of one large clot, tiny blood clots simultaneously plug the microscopic capillaries of three or more critical organs (usually the kidneys, lungs, brain, heart, skin, and adrenal glands) within less than 7 days, accompanied by severe systemic inflammation and a falling platelet count.

Me yasa likitoci zasu ba da jiyya guda uku a daidai lokaci guda ("Triple Therapy") don ceton mara lafiya tare da CAPS?¶

Historical data from the International CAPS Registry (covering over 500 patients worldwide) proved that treating CAPS with blood thinners alone or steroids alone failed in the majority of cases, because CAPS has three self-reinforcing engines: (1) Runaway fibrin and complement clotting in small vessels, (2) A fierce inflammatory cytokine storm on the blood vessel walls, and (3) High concentrations of circulating antiphospholipid autoantibodies. "Triple Therapy" attacks all three engines simultaneously: Intravenous Unfractionated Heparin stops clot propagation and inhibits complement, High-Dose IV Methylprednisolone shuts down the endothelial cytokine storm, and Daily Therapeutic Plasma Exchange (Plasmapheresis) and/or IVIG physically removes and neutralizes the autoantibodies, cutting mortality from over 75 percent down to roughly 30 percent.

Why can't nurses and doctors use the standard aPTT blood test to monitor intravenous Heparin in a patient with CAPS?¶

Patients with CAPS almost always have a circulating antiphospholipid antibody called a "Lupus Anticoagulant" (LA). Paradoxically, although a Lupus Anticoagulant causes severe blood clotting inside the human body, inside a glass laboratory test tube it binds to the phospholipid reagents used to run the standard activated Partial Thromboplastin Time (aPTT) test, artificially making the patient's baseline aPTT look prolonged (for example, 85 seconds) before a single drop of heparin is even given. If a clinician uses the aPTT to titrate the heparin drip, they will mistakenly think the patient's blood is "already too thin" and turn the heparin drip down to sub-therapeutic levels while the patient clots to death. Instead, IV Heparin in CAPS must always be monitored with a chromogenic Anti-Factor Xa (Anti-Xa) blood level (targeting 0.3 to 0.7 IU/mL), which is unaffected by the Lupus Anticoagulant.

Me yasa CAPS akai-akai yana haifar da kwatsam, Rikicin Adrenal (Addisonian shock) mai barazanar rai?¶

Kowanne daga cikin glandon adrenal na ku guda biyu (wanda ke zaune a saman kodan kuma yana samar da cortisol mai ɗorewa da aldosterone) yana karɓar jini ta ɗimbin ƙananan arteries, amma yana fitar da duk jininsa ta hanyar tsakiyar Adrenal Vein guda ɗaya. A yayin guguwar thrombotic na CAPS, ƙananan ƙwayoyin cuta suna toshe wannan jijiyar adrenal cikin sauƙi a bangarorin biyu. Tare da toshewar jijiyar fita, jini na jijiya yana dawowa a cikin duka glandan adrenal guda biyu har sai sun kumbura kuma suka tsage a ciki (jinin adrenal na adrenal da bugun jini). Wannan yana kawar da samar da cortisol na jiki a cikin dare, yana haifar da ciwo mai tsanani ko ciwon ciki, ƙarancin sodium, high potassium, da ƙananan jini mai mutuwa sai dai idan an yi maganin corticosteroids masu yawa na ciki (Methylprednisolone ko Hydrocortisone).

Me yasa marasa lafiya da ke da APS sau uku ko CAPS na farko ba za a taɓa canzawa daga Warfarin zuwa kwayar maganin rigakafi ta baka na zamani (DOAC) kamar Rivaroxaban ko Apixaban?¶

An dakatar da gwaje-gwaje na asibiti da yawa (ciki har da gwajin TRAPS da ASTRO-APS) da wuri bayan gano cewa marasa lafiya da ke da "Triple-Positive" Antiphospholipid Syndrome (tabbatacce ga Lupus Anticoagulant, Anti-Cardiolipin, da Anti-Beta-2-Glycoprotein-I) waɗanda suka ɗauki Direct Oral Anticorovagulants. apixaban) ya sha wahala mai ninki 4 zuwa 7 mafi girma na bugun jini da bugun zuciya fiye da marasa lafiya da ke shan Warfarin. Toshe ma'aunin jini guda ɗaya kawai (Factor Xa ko Factor IIa) tare da DOAC galibi bai isa ya dakatar da babban thrombin da haɓaka haɓakar ƙwayoyin rigakafin antiphospholipid sau uku ba, kuma canzawa daga Warfarin zuwa DOAC shine abin da aka rubuta yana haifar da babban bala'i APS.

Tushen da jagorar hukuma¶

• ** Jami'ar McMaster / ASH Jagoran Ayyukan Clinical (Legault K et al., * Ci gaban Jini*):** * McMaster RARE-Best Practices Guidelines Clinical Guidelines for Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome (Triple Therapy: Anticoagulation, Glucocortic) da Plamacortic.
• European Alliance of Associations for Rheumatology (EULAR, Tektonidou MG et al., Annals of the Rheumatic Diseases): EULAR Recommendations for the Management of Antiphospholipid Syndrome in Adults (Contraindication of DOACs in Triple-Positive APS and CAPS Management).
• International Consensus Statement on Classification Criteria and Treatment Guidelines for Catastrophic Antiphospholipid Syndrome (Asherson RA, Cervera R, et al., Lupus / Journal of Rheumatology): Preliminary Classification Criteria for Definite and Probable CAPS and Analysis of 500+ Patients from the International CAPS Registry.
• ** Ƙungiyar Biritaniya don Ciwon Jiki (BSH, Arachchillage DRJ et al.): ** * Sharuɗɗa akan Bincike da Gudanar da Ciwon Cutar Antiphospholipid da Catastrophic APS *.
• New England Journal of Medicine (NEJM) Review (Garcia D, Erkan D): Diagnosis and Management of the Antiphospholipid Syndrome and Complement Inhibition in CAPS.

Jagora masu alaƙa¶

• Adrenal crisis and Addison's disease emergency injection
• Heparin-induced thrombocytopenia (HIT) da VITT: 50 kashi platelet drop a ranar 5 zuwa 10 da Argatroban
• Eclampsia seizures, ciwon HELLP, preeclampsia bayan haihuwa, da kuma magnesium triage
• Sepsis da septic shock
• Lambobin gaggawa ta ƙasa